Bolt Biotherapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Bolt Biotherapeutics Capital Expenditures (CapEx) Growth & History (BOLT)
Bolt Biotherapeutics's capital expenditures (capex) was $72,000 for fiscal 2025.
View full Bolt Biotherapeutics company overviewBolt Biotherapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $72,000 | $31,000 | +75.61% |
| 2024 | 2024-12-31 | $41,000 | −$165,000 | −80.10% |
| 2023 | 2023-12-31 | $206,000 | −$1.7M | −89.45% |
| 2022 | 2022-12-31 | $2.0M | −$385,000 | −16.47% |
| 2021 | 2021-12-31 | $2.3M | −$924,000 | −28.33% |
| 2020 | 2020-12-31 | $3.3M | — | — |
Bolt Biotherapeutics quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q3.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $72,000 | $31,000 | +75.61% |
| Q4 2024 | 2024-12-31 | $0 | −$6,000 | — |
| Q3 2024 | 2024-09-30 | $41,000 | −$124,000 | −75.15% |
| Q2 2024 | 2024-06-30 | $0 | −$32,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$3,000 | — |
| Q4 2023 | 2023-12-31 | $6,000 | −$178,000 | −96.74% |
| Q3 2023 | 2023-09-30 | $165,000 | −$570,000 | −77.55% |
| Q2 2023 | 2023-06-30 | $32,000 | −$397,000 | −92.54% |
| Q1 2023 | 2023-03-31 | $3,000 | −$602,000 | −99.50% |
| Q4 2022 | 2022-12-31 | $184,000 | −$378,000 | −67.26% |
| Q3 2022 | 2022-09-30 | $735,000 | −$280,000 | −27.59% |
| Q2 2022 | 2022-06-30 | $429,000 | −$274,000 | −38.98% |
| Q1 2022 | 2022-03-31 | $605,000 | $547,000 | +943.10% |
| Q4 2021 | 2021-12-31 | $562,000 | −$336,000 | −37.42% |
| Q3 2021 | 2021-09-30 | $1.0M | −$136,000 | −11.82% |
| Q2 2021 | 2021-06-30 | $703,000 | −$137,000 | −16.31% |
| Q1 2021 | 2021-03-31 | $58,000 | −$315,000 | −84.45% |
| Q4 2020 | 2020-12-31 | $898,000 | — | — |
| Q3 2020 | 2020-09-30 | $1.2M | — | — |
| Q2 2020 | 2020-06-30 | $840,000 | — | — |
| Q1 2020 | 2020-03-31 | $373,000 | — | — |
Bolt Biotherapeutics capital expenditures (capex) trends
Over the last five fiscal years, Bolt Biotherapeutics's capital expenditures (capex) decreased from $3.3M to $72,000, a change of −$3.2M. The latest reported quarter, Q3 2025, shows $72,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bolt Biotherapeutics source filings ↗